Advertisement
UK markets close in 8 hours 1 minute
  • FTSE 100

    8,223.42
    -1.91 (-0.02%)
     
  • FTSE 250

    20,301.34
    +3.24 (+0.02%)
     
  • AIM

    763.87
    -2.05 (-0.27%)
     
  • GBP/EUR

    1.1823
    +0.0007 (+0.06%)
     
  • GBP/USD

    1.2644
    +0.0020 (+0.16%)
     
  • Bitcoin GBP

    48,033.67
    -716.48 (-1.47%)
     
  • CMC Crypto 200

    1,262.06
    -4.08 (-0.32%)
     
  • S&P 500

    5,477.90
    +8.60 (+0.16%)
     
  • DOW

    39,127.80
    +15.64 (+0.04%)
     
  • CRUDE OIL

    80.77
    -0.13 (-0.16%)
     
  • GOLD FUTURES

    2,312.00
    -1.20 (-0.05%)
     
  • NIKKEI 225

    39,341.54
    -325.53 (-0.82%)
     
  • HANG SENG

    17,717.33
    -372.60 (-2.06%)
     
  • DAX

    18,205.82
    +50.58 (+0.28%)
     
  • CAC 40

    7,619.80
    +10.65 (+0.14%)
     

Patterson Companies Full Year 2024 Earnings: In Line With Expectations

Patterson Companies (NASDAQ:PDCO) Full Year 2024 Results

Key Financial Results

  • Revenue: US$6.57b (up 1.5% from FY 2023).

  • Net income: US$185.9m (down 10% from FY 2023).

  • Profit margin: 2.8% (down from 3.2% in FY 2023). The decrease in margin was driven by higher expenses.

  • EPS: US$2.00 (down from US$2.14 in FY 2023).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Patterson Companies Meets Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.

Looking ahead, revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Healthcare industry in the US.

ADVERTISEMENT

Performance of the American Healthcare industry.

The company's shares are up 11% from a week ago.

Risk Analysis

Be aware that Patterson Companies is showing 3 warning signs in our investment analysis and 2 of those shouldn't be ignored...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com